The present study comprehensively uncovered the correlations of the class V SLRP member PODNL1 expression with the prognosis, immunotherapeutic response, TME immune infiltration, co-expression networks, mutation landscape and epigenetic regulation in a pan-cancer setting. The gene discussed is PODNL1; the disease is cancer.